ARTICLE | Company News
FDA committee to discuss Chelsea's Northera
October 9, 2013 11:42 PM UTC
Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) said FDA's Cardiovascular and Renal Drug Advisory Committee is tentatively scheduled to meet on Jan. 14, 2014, to discuss an NDA for Northera drox...